Ethical qualms about genetic prognosis

Canadian Medical Association Journal 188 (6):1-2 (2016)
  Copy   BIBTEX

Abstract

The debate about direct-to-consumer genetic testing has centred on whether consumers are the best judges of their own clinical care. Inthis article, I also examine whether the science of personalized medicine is really as advanced as its proponents claim, and how the availability of genetic markers affects decisions on who gets and does not get medical treatment.

Author's Profile

Donna Dickenson
Birkbeck, University of London

Analytics

Added to PP
2019-06-13

Downloads
225 (#61,182)

6 months
41 (#80,674)

Historical graph of downloads since first upload
This graph includes both downloads from PhilArchive and clicks on external links on PhilPapers.
How can I increase my downloads?